Mifeprex (mifepristone) / Danco Laboratories 
Welcome,         Profile    Billing    Logout  
 94 Diseases   58 Trials   58 Trials   2914 News 


«12...2526272829303132333435...3839»
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Review, Journal:  First trimester termination of pregnancy. (Pubmed Central) -  Mar 8, 2020   
    The combination of 200 mg mifepristone followed by 800 μg misoprostol 24-48 h later is recommended for first trimester medical TOP...Gastrointestinal upsets can occur in up to 50% of women, but major complications are rare. There was no lower limit of gestational week for TOP, although extra precaution is required for the confirmation of completion of procedures and exclusion of ectopic pregnancy.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Early-life manipulation of cortisol and its receptor alters stress axis programming and social competence. (Pubmed Central) -  Mar 4, 2020   
    During the first two months of life, juveniles were repeatedly treated with cortisol, mifepristone or control treatments...We suggest that these persistent changes in stress gene expression may represent an effective physiological mechanism for coping with stress. This article is part of the theme issue 'Developing differences: early-life effects and evolutionary medicine'.
  • ||||||||||  Motiva (nefiracetam) / Neuren, Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Dopaminergic D1 receptor signalling is necessary, but not sufficient for cued fear memory destabilisation. (Pubmed Central) -  Mar 4, 2020   
    This article is part of the theme issue 'Developing differences: early-life effects and evolutionary medicine'. The use of combination pharmacological treatment to stimulate memory destabilisation and impair reconsolidation has potential therapeutic benefits, without risking a maladaptive increase of fear.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal, IO Biomarker:  Effects of progesterone receptor on proliferation of uterine leiomyoma cells. (Pubmed Central) -  Feb 28, 2020   
    Different concentrations of Mifepristone (MIF), a progesterone receptor antagonist, were used to interfere with PR-M(+) and PR-M(-) cell lines, respectively...However, the expression of Caspase-3 protein on progesterone receptor M increased, while the expression of Bcl-2 decreased. Moreover, progesterone could induce progesterone receptor M to up-regulate apoptotic protein Caspase-3 and down-regulate anti-apoptotic protein Bcl-2, thus it could inhibit the apoptosis of primary cultured uterine leiomyoma cells and promote the proliferation of leiomyoma cells.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  The GCs-SGK1-ATP Signaling Pathway in Spinal Astrocytes Underlied Presurgical Anxiety-Induced Postsurgical Hyperalgesia. (Pubmed Central) -  Feb 25, 2020   
    Moreover, progesterone could induce progesterone receptor M to up-regulate apoptotic protein Caspase-3 and down-regulate anti-apoptotic protein Bcl-2, thus it could inhibit the apoptosis of primary cultured uterine leiomyoma cells and promote the proliferation of leiomyoma cells. These data suggested an important signaling pathway that affected the pain sensitivity after operation caused by presurgical anxiety.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Trial completion date, Trial primary completion date:  Medication Abortion Via Pharmacy Dispensing (clinicaltrials.gov) -  Feb 24, 2020   
    P4,  N=250, Recruiting, 
    Trial primary completion date: Dec 2019 --> Dec 2021 | Recruiting --> Active, not recruiting | Trial completion date: Dec 2020 --> Dec 2021 Trial completion date: Apr 2020 --> Jul 2020 | Trial primary completion date: Apr 2020 --> Jul 2020
  • ||||||||||  Review, Journal:  Medical Management of Cushing Disease. (Pubmed Central) -  Feb 24, 2020   
    Steroidogenesis inhibitors, centrally acting agents, and glucocorticoid receptor antagonists are currently available to treat hypercortisolism, and several novel agents are in development. Given the absence of head-to-head clinical trials, choice between treatments has to be individualized based on careful consideration of patient, tumor, and disease characteristics.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Preclinical, Journal:  Inhibitory effect of octyl-phenol and bisphenol A on calcium signaling in cardiomyocyte differentiation of mouse embryonic stem cells. (Pubmed Central) -  Feb 15, 2020   
    In addition, cells were treated with mifepristone (RU486), a synthetic steroid that has an affinity for progesterone receptor (Pgr), for one day starting on day 11...P4, OP, and BPA treatments reduced the intracellular calcium level. Taken together, these results indicate that EDCs (OP and BPA) has a structure similar to that of endogenous steroid hormones such as progesterone and estrogen, and OP and BPA act like progesterone to inhibit and disrupt cardiomyocyte differentiation of mESCs.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Medical technologies and abortion care in Eastern Uganda. (Pubmed Central) -  Feb 15, 2020   
    Manual Vacuum Aspirators (MVA), Dilation and Curettage (D&C), and medical abortifacients (Misoprostol, Mifepristone and Divabo) are available in clinical settings that offer abortion and post-abortion care in Uganda...Normalized and disciplinary power enact and reproduce unsafe and risky conditions, leading to poor abortion care outcomes. We illustrate the mechanisms of domination and tactics of resistance in abortion care, and expose conditions upon which unsafe and risky outcomes are contingent.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression. (Pubmed Central) -  Feb 14, 2020   
    The blockage of PGRMC1 activity may provide a novel treatment strategy for ovarian cancer. FUND: This work was supported by grants from the National Science Centre, Poland (2013/09/N/NZ5/01831 to DP-T; 2012/05/B/NZ5/01867 to MC), Academy of Finland (254366 to NAR), Moikoinen Cancer Research Foundation (to NAR) and EU PARP Cluster grant (UDA-POIG.05.01.00-005/12-00/NCREMFP to SW).
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Preclinical, Journal:  Mechanisms of Stress-Induced Spermatogenesis Impairment in Male Rats Following Unpredictable Chronic Mild Stress (uCMS). (Pubmed Central) -  Feb 14, 2020   
    RU486 treatment suppressed GR signaling and alleviated the damaging effects of stress, resulting in an increased epididymal sperm concentration. Overall, this work demonstrated for the first time that the activation of GR signaling mediates stress-induced spermatogenesis impairment and that this outcome is related to cell apoptosis and cell cycle arrest in germ cells.
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD)
    Journal:  HIF-1α Regulates Glucocorticoid-Induced Osteoporosis Through PDK1/AKT/mTOR Signaling Pathway. (Pubmed Central) -  Feb 13, 2020   
    MC3T3-E1 cells when treated with the glucocorticoid receptor antagonist RU486 along with dexamethasone showed enhanced HIF-1α expression...However, the HIF-1α antagonist 2-methoxyestradiol (2-ME) had a reverse effect in MC3T3-E1 cells exposed to dexamethasone...in vivo, the PDK1 agonist PS48 could maintain the bone mass of mice treated with dexamethasone. This study provides a new understanding of the mechanism of glucocorticoid-induced osteoporosis.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Trial completion date, Trial primary completion date:  Medication Abortion Via Pharmacy Dispensing (clinicaltrials.gov) -  Feb 12, 2020   
    P4,  N=250, Recruiting, 
    This study provides a new understanding of the mechanism of glucocorticoid-induced osteoporosis. Trial completion date: Dec 2019 --> Apr 2020 | Trial primary completion date: Dec 2019 --> Apr 2020
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Low-dose mifepristone increased angiogenesis in a manner involving AQP1. (Pubmed Central) -  Feb 9, 2020   
    Low-dose mifepristone increased angiogenesis in a manner involving AQP1. This affords a new insight into the molecular mechanism underpinning the angiogenic effects of low-dose mifepristone.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories, Cervidil (dinoprostone) / Ferring
    Clinical, Journal:  Safety and efficacy of mifepristone versus dinoprostone gel in induction of labor: A randomized controlled trial. (Pubmed Central) -  Feb 9, 2020   
    This affords a new insight into the molecular mechanism underpinning the angiogenic effects of low-dose mifepristone. The results of the study suggest that oral administration of 200 mg mifepristone in term patients is an effective method of labor induction; and is more convenient and equally safe as compared to intravaginal instillation of dinoprostone.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Review, Journal:  Twelve years after abortion decriminalization in Mexico City: Can we still remain an island of liberties? (Pubmed Central) -  Feb 8, 2020   
    The road toward increasing access to abortion services at the MX-MOH included a shift from dilation and curettage (D&C) to medical abortion (MA), first with the misoprostol-alone regimen, followed by the combined mifepristone-misoprostol regimen...However, women from indigenous groups residing in rural areas, those with low schooling, and adolescents with an unintended pregnancy who live in rural, urban, peri-urban districts, and at the state level are underserved despite being legally eligible to receive abortion services. Therefore, information and services for the disadvantaged groups need to be strengthened.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Effects of unpaired 1 gene overexpression on the lifespan of Drosophila melanogaster. (Pubmed Central) -  Feb 7, 2020   
    Conditional overexpression of upd1 in different tissues of Drosophila imago induces pro-aging or pro-longevity effects in tissue-dependent manner. The effects of upd1 overexpression on lifespan are accompanied by the transcription activation of genes for the components of JAK/STAT pathway.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists. (Pubmed Central) -  Feb 7, 2020   
    Our results also demonstrate that, if the addition of mifepristone to medical treatment with misoprostol proves to be more efficient than misoprostol alone, gynaecologists are willing to prescribe mifepristone in the future. Whether the addition is indeed more effective than misoprostol alone, will be the subject of a multicentre, double-blind, placebo-controlled randomised controlled trial, planned to begin in the first half of 2018.
  • ||||||||||  doxorubicin hydrochloride / Generic mfg.
    Journal:  Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agents. (Pubmed Central) -  Feb 7, 2020   
    Six drugs (afatinib, celecoxib, doramapimod, mifepristone, MK-2206 and rosiglitazone) were evaluated for their ability to reverse resistance of MRP1-overexpressing H69AR lung cancer cells against vincristine, doxorubicin and etoposide...Anti-cancer agents that exhibit MRP1 inhibition may be used to reverse multidrug resistance or to improve the efficacy and reduce the toxicity of various cancer chemotherapies. On the other hand, anti-cancer drugs that did not interact with MRP1 carry a low risk for developing MRP1-mediated resistance.
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD), prednisone / Generic mfg.
    Journal:  Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression. (Pubmed Central) -  Feb 7, 2020   
    Glucocorticoids, including dexamethasone (DEX) and prednisone (PRED), have been prescribed in patients with neoplastic disease as cytotoxic agents or comedications...The effects of PRED were restored by a GR antagonist RU486 in GR-positive MCA-SVHUC cells, while PRED failed to inhibit the neoplastic transformation of GR knockdown cells...Finally, DEX was found to considerably induce both transactivation (activation of glucocorticoid-response element mediated transcription and expression of its targets) and transrepression (suppression of nuclear factor-kappa B transactivation and expression of its regulated genes) of GR in SVHUC cells, while PRED more selectively induced GR transrepression. These findings suggest that PRED could prevent urothelial tumorigenesis presumably via inducing GR transrepression.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    NALCN Expression Is Regulated by Progesterone and Estrogen in Human Myometrial Smooth Muscle Cells (ENDOExpo) -  Feb 7, 2020 - Abstract #ENDO2020ENDO_3120;    
    Conversely, treatment with the ER antagonist, ICI 182,780, significantly increased NALCN mRNA expression, while treatment with the PR antagonist RU486 significantly decreased NALCN mRNA expression suggesting E2 and P4 work through their respective receptors to regulate NALCN...This data reveals a new mechanism by which NALCN is regulated in the myometrium and may suggest a novel role for NALCN during pregnancy. Further investigation into these novel roles can provide an insight into potential targets to modulate uterine quiescence and contractility.
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD), Mifeprex (mifepristone) / Danco Laboratories
    Case Report: Mifepristone Taper in an Individual with Equivocal Cushing’s Syndrome Screening Tests (ENDOExpo) -  Feb 7, 2020 - Abstract #ENDO2020ENDO_2060;    
    We describe our experience stopping mifepristone and performing re-evaluation. We propose a tapering protocol in the setting of potentially untreated Cushing's Syndrome and suggest use as a bridge therapy to surgical intervention rather than destination therapy.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Pathways to seeking medication abortion care: A qualitative research in Uttar Pradesh, India. (Pubmed Central) -  Jan 27, 2020   
    Pharmacists could be trained or incentivized to improve their quality of care to facilitate adequate exchange of information on MA. Since, for most couples, the male partner purchases MA, information approaches or tools are needed that pharmacists can give men to share directly with the MA user.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Preclinical, Journal:  Research on hemostatic effect and mechanism of carbonized Scutellariae Radix on rats of uterine bleeding (Pubmed Central) -  Jan 16, 2020   
    Forty female rats conceived on the same day received mifepristone(11...As compared with the model group,the uterine bleeding volume was decreased significantly in the carbonized Scutellariae Radix medium dose and high dose groups; endometrial repair was promoted,and the microvessel density of endometrial tissues was increased significantly; the contents of IL-1β and TNF-α in the plasma of rats were decreased significantly,while the content of IL-6 in the plasma of rats was increased significantly; the expression levels of IL-1β and TNF-α mRNA in the uterus of rats were decreased and the expression level of IL-6 mRNA showed an increase; the protein expressions of VEGF,MMP-2 and MMP-9 were decreased significantly in carbonized Scutellariae Radix medium and high dose groups. In conclusion,carbonized Scutellariae Radix showed good hemostatic effect,and its mechanism may be related to the repair of endometrium and inhibition of inflammatory reaction.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Trial primary completion date:  Cervical Preparation With Mifepristone Prior to Osmotic Dilators (clinicaltrials.gov) -  Jan 14, 2020   
    P2,  N=66, Recruiting, 
    GR activation in radioresistant cells mediates androgen independence and facilitates PCa progression. Trial primary completion date: Nov 2019 --> Jun 2020
  • ||||||||||  Decadron (dexamethasone) / Merck (MSD), norethindrone / Generic mfg.
    Journal:  The injectable contraceptive medroxyprogesterone acetate attenuates Mycobacterium tuberculosis-specific host immunity through the glucocorticoid receptor. (Pubmed Central) -  Jan 10, 2020   
    We recruited human immunodeficiency virus-uninfected females, not taking any contraceptives, from Cape Town, South Africa, to evaluate the effect of MPA, NET-A, and dexamethasone on Mtb containment in monocyte-derived macrophages co-incubated with purified protein derivative (PPD)-driven peripheral blood-derived effector cells...Antagonizing the glucocorticoid receptor with mifepristone (RU486) abrogated the reduction in Mtb containment...MPA, but not NET-A, subverts mycobacterial containment in vitro, and downregulates pathways associated with protective CD8+ and CD4+-related host immunity via the glucocorticoid receptor. These data potentially inform the selection and use of injectable contraceptives in TB endemic countries.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Journal:  Effect of glucocorticoids on androgen biosynthesis in the testes of the toad Rhinella arenarum (Amphibia, Anura). (Pubmed Central) -  Jan 9, 2020   
    Corticosterone inhibits androgen production via the GR because the GR antagonist RU486 prevents corticosterone-induced inhibition of testosterone...On the other hand, corticosterone had no effect on the amount of steroidogenic acute regulator protein. These results suggest that GCs inhibit steroidogenesis in toad testes by reducing of Cyp450 activity via a GR-mediated mechanism.
  • ||||||||||  Mifeprex (mifepristone) / Danco Laboratories
    Trial initiation date:  Assessing Medical Menstrual Regulation in the United States (clinicaltrials.gov) -  Jan 8, 2020   
    P2,  N=284, Recruiting, 
    These results suggest that GCs inhibit steroidogenesis in toad testes by reducing of Cyp450 activity via a GR-mediated mechanism. Initiation date: Oct 2019 --> Jan 2020